txs123

Takemi Sato, MD

Contact Dr. Sato

111 South 11th Street
Suite 4240
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma
  2. Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes
  3. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases
  4. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
  5. Co-Targeting HGF/cMET Signaling with MEK Inhibitors in metastatic uveal melanoma
  6. Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
  7. Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from ocular melanoma
  8. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma. Comparison with Institutional Controls
  9. Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment
  10. Immune check point inhibitors combination in melanoma: Worth the toxicity?
  11. Autologous melanoma cell vaccine using monocyte-derived dendritic cells (NBS20/eltrapuldencel-T)
  12. Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization
  13. Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography
  14. Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
  15. Successes and setbacks of early investigational drugs for melanoma
  16. Paracrine effect of NRG1 and HGF drives resistance to MEK inhibitors in metastatic uveal melanoma
  17. Biology of advanced uveal melanoma and next steps for clinical therapeutics
  18. Uveal melanoma metastatic to the liver: Chemoembolization with 1,3-bis-(2-chloroethyl)-1-nitrosourea
  19. Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases
  20. Treatment strategies for clinically detectable metastatic uveal melanoma